Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience
This plain language summary describes a study in which researchers investigated a new tool called Raman spectroscopy in the detection and monitoring of blood cancer.
Read the full article here.
The original article on which this plain language summary is based is titled ‘Nanoparticle surface-enhanced Raman spectroscopy as a noninvasive, label-free tool to monitor hematological malignancy’ and was published in Nanomedicine. Read the original article here.
This plain language summary from Neurodegenerative Disease Management describes the MAGNIFY-MS study, which investigated whether cladribine tablets affect how well the body responds to flu and chickenpox virus vaccines in people with multiple sclerosis.
Read the full article here.
The original article on which this plain language summary is based is titled ‘Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis’ and was published in the Multiple Sclerosis Journal. Read the original article here.
This plain language summary from Immunotherapy describes the VOLTAIRE-CD study, in which researchers compared BI 695501, a biosimilar to treat Crohn’s disease, with the original drug, adalimumab.
Read the full article here.
The original article on which this plain language summary is based is titled ‘Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn’s disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial’ and was published in The Lancet Gastroenterology and Hepatology. Read the original article here.
This plain language summary from Future Virology describes part of a clinical study of the Pfizer-BioNTech COVID-19 vaccine. The part of the study described was focused on participants 12- to 15-years old and was ongoing at the time of publication, meaning the final results may be different from the results included in this summary.
Read the full article here.
The original article on which this plain language summary is based is titled ‘Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents’ and was published in the New England Journal of Medicine. Read the original article here.
This plain language summary from Future Virology describes part of a clinical study of the Pfizer-BioNTech COVID-19 vaccine. The part of the study described was ongoing at the time of publication, meaning the final results may be different from the results included in this summary.
Read the full article here.
The original article on which this plain language summary is based is titled ‘Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months’ and was published in the New England Journal of Medicine. Read the original article here.